Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy
Open Access
Abstract
Emerging evidence indicates that cancer cells can mimic characteristics of embryonic development, promoting their development and progression. Cancer cells share features with embryonic development, characterized by robust proliferation and differentiation regulated by signaling pathways such as Wnt, Notch, hedgehog, and Hippo signaling. In certain phase, these cells also mimic embryonic diapause and fertilized egg implantation to evade treatments or immune elimination and promote metastasis. Additionally, the upregulation of ATP‐binding cassette (ABC) transporters, including multidrug resistance protein 1 (MDR1), multidrug resistance‐associated protein 1 (MRP1), and breast cancer‐resistant protein (BCRP), in drug‐resistant cancer cells, analogous to their role in placental development, may facilitate chemotherapy efflux, further resulting in treatment resistance. In this review, we concentrate on the underlying mechanisms that contribute to tumor development and progression from the perspective of embryonic development, encompassing the dysregulation of developmental signaling pathways, the emergence of dormant cancer cells, immune microenvironment remodeling, and the hyperactivation of ABC transporters. Furthermore, we synthesize and emphasize the connections between cancer hallmarks and embryonic development, offering novel insights for the development of innovative cancer treatment strategies.Keywords
Funding Information
- National Key Research and Development Program of China (2016YFC1200200, 2020YFA0509400)
- National Natural Science Foundation of China (81821002, 82130082, 82341004, 82303838)
This publication has 546 references indexed in Scilit:
- A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumorsInvestigational New Drugs, 2013
- Acute B lymphoblastic leukaemia‐propagating cells are present at high frequency in diverse lymphoblast populationsEMBO Molecular Medicine, 2012
- Frizzled7 as an emerging target for cancer therapyCellular Signalling, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The Hippo Signaling Pathway in Development and CancerDevelopmental Cell, 2010
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor GrowthCell, 2010
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cellsJournal of Cancer Research and Clinical Oncology, 2010
- Co‐delivery of Doxorubicin and Bcl‐2 siRNA by Mesoporous Silica Nanoparticles Enhances the Efficacy of Chemotherapy in Multidrug‐Resistant Cancer CellsSmall, 2009
- The Canonical Notch Signaling Pathway: Unfolding the Activation MechanismCell, 2009